Androgen Receptor Increases and Negative Expression of GCDFP-15 in Primary Ductal Adenocarcinoma of the Lacrimal Gland: a Case Description
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
The poor prognosis of lacrimal gland adenocarcinoma: a clinical study and literature review.
Liu R, Ren T, Li J, Wang N, Xu L, Guo Q J Cancer Res Clin Oncol. 2024; 150(1):26.
PMID: 38263473 PMC: 10806072. DOI: 10.1007/s00432-023-05510-7.
References
1.
Ishida M, Iwai M, Yoshida K, Kagotani A, Kohzaki H, Arikata M
. Primary ductal adenocarcinoma of the lacrimal sac: the first reported case. Int J Clin Exp Pathol. 2013; 6(9):1929-34.
PMC: 3759502.
View
2.
Kubota T, Moritani S, Ichihara S
. Clinicopathologic and immunohistochemical features of primary ductal adenocarcinoma of lacrimal gland: five new cases and review of literature. Graefes Arch Clin Exp Ophthalmol. 2013; 251(8):2071-6.
DOI: 10.1007/s00417-013-2350-3.
View
3.
Darb-Esfahani S, von Minckwitz G, Denkert C, Ataseven B, Hogel B, Mehta K
. Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes. BMC Cancer. 2014; 14:546.
PMC: 4122770.
DOI: 10.1186/1471-2407-14-546.
View
4.
Yao J, Shah M, Ito T, Bohas C, Wolin E, Van Cutsem E
. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med. 2011; 364(6):514-23.
PMC: 4208619.
DOI: 10.1056/NEJMoa1009290.
View
5.
Touil A, El Abbassi S, Echchikhi Y, Maher M, Kebdani T, Benjaafar N
. Adenocarcinoma of the lacrimal gland: a case report. J Med Case Rep. 2017; 11(1):257.
PMC: 5592714.
DOI: 10.1186/s13256-017-1412-2.
View